Honolulu — GE HealthCare has introduced its latest innovation in magnetic resonance imaging with the debut of the SIGNA™ Sprint, a wide bore 1.5T MRI system designed to deliver performance previously thought achievable only at higher field strengths. Unveiled at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025 conference, the FDA 510(k) pending system aims to redefine diagnostic capabilities in cardiology, oncology, and advanced clinical research.
The SIGNA Sprint addresses the growing demand for precise imaging in diseases such as cardiovascular conditions and cancer, which account for a significant share of global mortality. By integrating advanced gradient technology and AI-driven imaging enhancements, the system offers faster scans and higher-resolution images, enabling more accurate assessments and potentially earlier diagnoses. The system features gradient performance of 65 mT/m and 200 T/m/s per axis, designed to visualize sub-millimeter structures with exceptional clarity.
Equipped with deep learning-based reconstruction tools, SIGNA Sprint supports quantitative imaging that goes beyond anatomical scans to help clinicians understand tissue characteristics. These capabilities are particularly beneficial in oncology, where treatment planning and response monitoring rely on detailed and consistent imaging. The system is also engineered to accelerate cardiac MRI scans, reducing the expertise and time typically required for interpretation.
“We are driven to push the boundaries of what’s possible in MRI,” said Kelly Londy, CEO of MR at GE HealthCare. “Our goal is to set a new standard in diagnostic research and precision care that allows for earlier detection and better outcomes.”
Designed with both clinical performance and patient comfort in mind, SIGNA Sprint includes a spacious 70 cm wide bore, free-breathing capabilities, and the flexible AIR™ Coils system that conforms to the patient like a blanket. The scanner incorporates GE HealthCare’s suite of built-in AI tools, including AIR™ Recon DL, Sonic DL™, and AIR x™, to support high-quality imaging even in complex anatomical regions.
The introduction of SIGNA Sprint marks GE HealthCare’s latest move to expand the capabilities of 1.5T MRI, traditionally considered more limited than 3.0T systems. The company is also showcasing other innovations at ISMRM 2025, including SIGNA™ MAGNUS, a head-only MR scanner designed for ultra-high resolution neuroimaging; Sonic DL™ 3D, a deep-learning powered solution for faster imaging across clinical applications; and Freelium™, a helium-free magnet platform currently in development.
Together, these technologies reflect GE HealthCare’s commitment to improving imaging performance while enhancing sustainability, accessibility, and patient-centered care.
